From the Journals

Dementia prevalence study reveals inequities


 

FROM JAMA NEUROLOGY

Acknowledging the needs of the historically underrepresented

Lealani Mae Acosta, MD, MPH, associate professor of neurology at Vanderbilt University Medical Center, Nashville, Tenn., applauded the investigators for their “conscious effort to expand representation of historically underrepresented minorities.”

Lealani Mae Acosta, MD, MPH, is an associate professor of neurology at Vanderbilt University Medical Center, Nashville, Tennessee.

Dr. Lealani Mae Acosta

The findings themselves support what has been previously reported, Dr. Acosta said in an interview, including the disproportionate burden of cognitive disorders among people of color and those with less education.

Clinicians need to recognize that certain patient groups face increased risks of cognitive disorders, and should be screened accordingly, Dr. Acosta said, noting that all aging patients should undergo such screening. The push for screening should also occur on a community level, along with efforts to build trust between at-risk populations and health care providers.

While Dr. Acosta reiterated the importance of these new data from Black and Hispanic individuals, she noted that gaps in representation remain, and methods of characterizing populations deserve refinement.

“I’m a little bit biased because I’m an Asian physician,” Dr. Acosta said. “As much as I’m glad that they’re highlighting these different disparities, there weren’t enough [participants in] specific subgroups like American Indian or Alaska Native, Asian, Native Hawaiian or Pacific Islander, to be able to identify specific trends within [those groups] that are, again, historically underrepresented patient populations.”

Grouping all people of Asian descent may also be an oversimplification, she added, as differences may exist between individuals originating from different countries.

“We always have to be careful about lumping certain groups together in analyses,” Dr. Acosta said. “That’s just another reminder to us – as clinicians, as researchers – that we need to do better by our patients by expanding research opportunities, and really studying these historically underrepresented populations.”

The study was supported by the National Institute on Aging. The investigators disclosed additional relationships with the Alzheimer’s Association and the National Institutes of Health. Dr. Acosta reported no relevant competing interests.

Pages

Recommended Reading

Vitamins or cocoa: Which preserves cognition?
MDedge Family Medicine
COVID-19 linked to increased Alzheimer’s risk
MDedge Family Medicine
Not just a bad dream: Nightmares may predict dementia
MDedge Family Medicine
Positive top-line phase 3 data for lecanemab in early Alzheimer’s
MDedge Family Medicine
New ICD-10-CM codes a ‘big switch-over’ for neurocognitive disorders
MDedge Family Medicine
Older diabetes drugs linked to dementia risk -- one lower, one higher
MDedge Family Medicine
Dementia signs detected years before diagnosis
MDedge Family Medicine
No effect of diet on dementia risk?
MDedge Family Medicine
How can I keep from losing my mind?
MDedge Family Medicine
Viagra, Cialis, and Alzheimer’s risk: New data
MDedge Family Medicine